Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year

Published: June 3, 2019

Khiron Life Sciences Corp., a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce the completion of construction and the initiation of operations in its cultivation, extraction, and analysis facilities in Ibague, Colombia, where significant progress has been made towards the commercial registration and production of medical cannabis products targeting 6 million potential patients across the country.

Khiron currently owns and operates one of the most sophisticated medical cannabis cultivation and processing facilities in Latin America. To date, the company has:

  • Completed development of a state-of-the-art, 14,000 square foot GMP and ISO 17025 compliant extraction and analysis lab

  • Obtained approval from the National Cultivar Registry and Colombian Institute of Agriculture (ICA) to list a proprietary selection of strains forming a targeted portfolio to address the major conditions of pain, epilepsy and sleep disorders. This approval positions the company to initiate commercial registration, production and sale of its medical cannabis products across Colombia

  • Begun construction of additional greenhouses to complement Khiron’s initial 80,000 square foot greenhouse

  • Established distribution networks to supply high quality medical cannabis produced in Khiron’s main facility, with signed agreements with 903 pharmacies across Colombia and Khiron Clinics